36 related articles for article (PubMed ID: 8946928)
1. Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18(Ink4c) and p19(Ink4d).
Zindy F; den Besten W; Chen B; Rehg JE; Latres E; Barbacid M; Pollard JW; Sherr CJ; Cohen PE; Roussel MF
Mol Cell Biol; 2001 May; 21(9):3244-55. PubMed ID: 11287627
[TBL] [Abstract][Full Text] [Related]
2. INK4d-deficient mice are fertile despite testicular atrophy.
Zindy F; van Deursen J; Grosveld G; Sherr CJ; Roussel MF
Mol Cell Biol; 2000 Jan; 20(1):372-8. PubMed ID: 10594039
[TBL] [Abstract][Full Text] [Related]
3. NKAP Regulates Senescence and Cell Death Pathways in Hematopoietic Progenitors.
Shapiro MJ; Anderson J; Lehrke MJ; Chen M; Nelson Holte M; Shapiro VS
Front Cell Dev Biol; 2019; 7():214. PubMed ID: 31632967
[TBL] [Abstract][Full Text] [Related]
4. Examining the role of phosphorylation of p19
Msallam M; Sun H; Meledin R; Franz P; Brik A
Chem Sci; 2020 Jun; 11(21):5526-5531. PubMed ID: 32874495
[TBL] [Abstract][Full Text] [Related]
5. Cyclin-dependent kinase inhibitors in malignant hematopoiesis.
Schirripa A; Sexl V; Kollmann K
Front Oncol; 2022; 12():916682. PubMed ID: 36033505
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional repression of CDKN2D by PML/RARĪ± contributes to the altered proliferation and differentiation block of acute promyelocytic leukemia cells.
Wang Y; Jin W; Jia X; Luo R; Tan Y; Zhu X; Yang X; Wang X; Wang K
Cell Death Dis; 2014 Oct; 5(10):e1431. PubMed ID: 25275592
[TBL] [Abstract][Full Text] [Related]
7. p19(INK4d) mRNA and protein expression as new prognostic factors in ovarian cancer patients.
Felisiak-Golabek A; Dansonka-Mieszkowska A; Rzepecka IK; Szafron L; Kwiatkowska E; Konopka B; Podgorska A; Rembiszewska A; Kupryjanczyk J
Cancer Biol Ther; 2013 Oct; 14(10):973-81. PubMed ID: 24022213
[TBL] [Abstract][Full Text] [Related]
8. Mutation testing in melanoma families: INK4A, CDK4 and INK4D.
Newton Bishop JA; Harland M; Bennett DC; Bataille V; Goldstein AM; Tucker MA; Ponder BA; Cuzick J; Selby P; Bishop DT
Br J Cancer; 1999 Apr; 80(1-2):295-300. PubMed ID: 10390011
[TBL] [Abstract][Full Text] [Related]
9. CDKN2 (MTS1/p16INK4A) gene alterations in hematological malignancies.
Uchida T; Kinoshita T; Saito H; Hotta T
Leuk Lymphoma; 1997 Feb; 24(5-6):449-61. PubMed ID: 9086436
[TBL] [Abstract][Full Text] [Related]
10. p21WAF1 mutations and human malignancies.
Shiohara M; Koike K; Komiyama A; Koeffler HP
Leuk Lymphoma; 1997 Jun; 26(1-2):35-41. PubMed ID: 9250785
[TBL] [Abstract][Full Text] [Related]
11. Alterations of the cyclin-dependent kinase inhibitor p19 (INK4D) is rare in hematopoietic malignancies.
Shiohara M; Spirin K; Said JW; Gombart AF; Nakamaki T; Takeuchi S; Hatta Y; Morosetti R; Tasaka T; Seriu T; Bartram C; Miller CW; Tomonaga M; Koeffler HP
Leukemia; 1996 Dec; 10(12):1897-900. PubMed ID: 8946928
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies.
Kawamata N; Morosetti R; Miller CW; Park D; Spirin KS; Nakamaki T; Takeuchi S; Hatta Y; Simpson J; Wilcyznski S
Cancer Res; 1995 Jun; 55(11):2266-9. PubMed ID: 7757974
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of the INK4 family of genes in prostate carcinomas.
Park DJ; Wilczynski SP; Pham EY; Miller CW; Koeffler HP
J Urol; 1997 May; 157(5):1995-9. PubMed ID: 9112579
[TBL] [Abstract][Full Text] [Related]
14. Absence of p16 and p27 gene rearrangements and mutations in de novo myelodysplastic syndromes.
Papageorgiou SG; Pappa V; Papageorgiou E; Tsirigotis P; Kontsioti F; Panani A; Dervenoulas J; Economopoulos T
Eur J Haematol; 2005 Sep; 75(3):193-8. PubMed ID: 16104874
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of a family of cyclin-dependent kinase inhibitor genes (p15/MTS2/INK4b and p18/INK4c) in non-small cell lung cancers.
Kawamata N; Miller CW; Koeffler HP
Mol Carcinog; 1995 Dec; 14(4):263-8. PubMed ID: 8519415
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
